Page 829 - Veterinary Immunology, 10th Edition
P. 829

These may cause intense local inflammation, or they may present as
  VetBooks.ir  a generalized vascular disturbance such as purpura. A type III

               reaction can occur in the eyes of dogs vaccinated against infectious
               canine hepatitis (see Fig. 27.8). Some rabies vaccines may induce a

               local complement-mediated vasculitis leading to ischemic
               dermatitis and local alopecia. This type of reaction is most often
               seen in small dogs such as Dachshunds, Miniature Poodles, Bichon
               Frises, and Terriers.

                  Type IV hypersensitivity reactions may occur in response to
               vaccination, but a more common reaction is granuloma formation at
               the site of inoculation. This may be a response to depot adjuvants
               containing alum or oil. Vaccines containing a water-in-oil adjuvant

               produce larger and more persistent lesions at injection sites than
               vaccines containing alum and aluminum hydroxide. These lesions
               can be granulomas or sterile abscesses. If the skin is dirty at the
               injection site, these abscesses may become infected. For this reason,

               it is inappropriate to administer vaccines intramuscularly to
               animals used for human consumption.
                  Postvaccinal canine distemper virus encephalitis is a rare
               complication that may develop after administration of a modified

               live canine distemper vaccine. The affected animal may show
               aggression, incoordination, and seizures or other neurological
               signs. The pathogenesis of this condition is unknown, but it may be
               due to residual virulence, increased susceptibility, or triggering of a

               latent paramyxovirus by the vaccine.


               Errors in Manufacture or Administration


               Some problems associated with vaccine use may be due to poor
               production or administration. Thus some modified live vaccines

               may retain the ability to cause disease. For example, some modified
               live herpes vaccines or calicivirus vaccines given intranasally may
               spread to the oropharynx and result in persistent infection. Indeed,

               such a virus vaccine may infect (and protect) other animals in
               contact. Even if these vaccines do not cause overt disease, they may
               reduce the rate of growth of farm animals with significant economic
               consequences.
                  Some vaccines may trigger a mild immunosuppression. For






                                                         829
   824   825   826   827   828   829   830   831   832   833   834